These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2922649)

  • 1. HMOs: the failed promise.
    Kushner J
    Surg Neurol; 1989 Feb; 31(2):120-1. PubMed ID: 2922649
    [No Abstract]   [Full Text] [Related]  

  • 2. Squeezing through HMOs' rough times.
    Wehrwein P
    Manag Care; 1998 Jun; 7(6):24-6, 31-4. PubMed ID: 10180800
    [No Abstract]   [Full Text] [Related]  

  • 3. The case for the HMOs.
    Pierson B
    Colo Med; 1980 Mar; 77(3):96-7. PubMed ID: 7363574
    [No Abstract]   [Full Text] [Related]  

  • 4. Financing health promotion and education programs in HMOs.
    Zapka JG; Mullen PD
    Health Care Manage Rev; 1985; 10(4):63-71. PubMed ID: 4055379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contracting with HMOs.
    Hardy CR
    Hosp Financ Manage; 1976 Aug; 30(8):10-2, 14. PubMed ID: 10236434
    [No Abstract]   [Full Text] [Related]  

  • 6. Market responses to HMOs: price competition or rivalry?
    McLaughlin CG
    Inquiry; 1988; 25(2):207-18. PubMed ID: 2968311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning, budgeting and cost control in HMOs.
    Bisbee GE; McCarthy MM
    Inquiry; 1979; 16(1):22-30. PubMed ID: 155036
    [No Abstract]   [Full Text] [Related]  

  • 8. Do Medicare HMOs cost shift?
    Feldman R; Wholey D; Christianson JB
    Inquiry; 1998; 35(3):315-31. PubMed ID: 9809059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 1980s: the rise of HMOs and marketplace competition.
    Johnson RL
    Hosp Prog; 1979 Jun; 60(6):38-43, 66. PubMed ID: 437739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMOs: financial feasibility, planning, and control.
    Willis DB
    Top Health Care Financ; 1987; 13(3):32-7. PubMed ID: 3551192
    [No Abstract]   [Full Text] [Related]  

  • 11. Weaker HMOs will seek concessions from hospitals for 2002 as medical cost rise.
    Health Care Strateg Manage; 2001 Jun; 19(6):16-7, 1. PubMed ID: 11409092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaiser's financial strategies and some cues for other HMOs.
    Vraciu RA; Starkweather DB
    Health Care Manage Rev; 1978; 3(1):29-40. PubMed ID: 10306296
    [No Abstract]   [Full Text] [Related]  

  • 13. HMOs: where are the savings?
    Cooney EK
    Bests Rev Life Health Insur Ed; 1986 Oct; 87(6):26-32, 136. PubMed ID: 10278416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New capitation scenarios for HMO Medicare risk contracting.
    Grimaldi PL
    Healthc Financ Manage; 1997 Feb; 51(2):35-6, 38. PubMed ID: 10164874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are fee-for-service costs increasing faster than HMO costs?
    Newhouse JP; Schwartz WB; Williams AP; Witsberger C
    Med Care; 1985 Aug; 23(8):960-6. PubMed ID: 3927076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marketing and finance issues in provider-sponsored Medicare HMOs.
    Laleman M; Scibilia K
    Healthc Strateg; 1998 Mar; 2(3):1-6. PubMed ID: 10345999
    [No Abstract]   [Full Text] [Related]  

  • 17. Automatic capitation adjusters.
    Shouldice RG
    Med Group Manage J; 1989; 36(1):16-8. PubMed ID: 10291908
    [No Abstract]   [Full Text] [Related]  

  • 18. The hidden costs of HMOs.
    Winsberg GR
    Bus Health; 1985 Dec; 3(2):18-21. PubMed ID: 10274725
    [No Abstract]   [Full Text] [Related]  

  • 19. Elements of provider risk under prepaid health plans.
    Gold BG; Johnson TB
    Hosp Cap Finance; 1985; 2(3):3-6. PubMed ID: 10272736
    [No Abstract]   [Full Text] [Related]  

  • 20. 1982 Supreme Court decision destroys fee-for-service fosters HMOs with financial incentives.
    Gale AH
    Mo Med; 1997 Dec; 94(12):687-9. PubMed ID: 9420420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.